Together this analysis linked the different methylation scores with distinct somatic genomic aberrations in breast cancers, and strongly implicated p53 somatic mutation with the loss of methylation in CpG islands that together constitute the ML score. This evidence concerns the gene TP53 and breast carcinoma.